Deals this week: Spero Therapeutics, BioCryst Pharmaceuticals, Breath Therapeutics Holding

Spero Therapeutics has announced it has raised $51.7m in a series C financing round led by GV (formerly Google Ventures).

Source: Drug Development Technology - March 10, 2017 Category: Pharmaceuticals Source Type: news